Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $5.87 billion. The enterprise value is $7.64 billion.
| Market Cap | 5.87B |
| Enterprise Value | 7.64B |
Important Dates
The last earnings date was Wednesday, April 22, 2026, before market open.
| Earnings Date | Apr 22, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
TMHC has 93.43 million shares outstanding. The number of shares has decreased by -5.81% in one year.
| Current Share Class | 93.43M |
| Shares Outstanding | 93.43M |
| Shares Change (YoY) | -5.81% |
| Shares Change (QoQ) | -1.14% |
| Owned by Insiders (%) | 0.57% |
| Owned by Institutions (%) | 106.09% |
| Float | 92.86M |
Valuation Ratios
The trailing PE ratio is 9.35 and the forward PE ratio is 11.57.
| PE Ratio | 9.35 |
| Forward PE | 11.57 |
| PS Ratio | 0.77 |
| Forward PS | 0.84 |
| PB Ratio | 0.95 |
| P/TBV Ratio | 1.05 |
| P/FCF Ratio | 8.54 |
| P/OCF Ratio | 8.05 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.23, with an EV/FCF ratio of 11.10.
| EV / Earnings | 11.44 |
| EV / Sales | 1.00 |
| EV / EBITDA | 7.23 |
| EV / EBIT | 7.53 |
| EV / FCF | 11.10 |
Financial Position
The company has a current ratio of 9.26, with a Debt / Equity ratio of 0.39.
| Current Ratio | 9.26 |
| Quick Ratio | 1.04 |
| Debt / Equity | 0.39 |
| Debt / EBITDA | 2.25 |
| Debt / FCF | 3.51 |
| Interest Coverage | 20.42 |
Financial Efficiency
Return on equity (ROE) is 11.11% and return on invested capital (ROIC) is 9.71%.
| Return on Equity (ROE) | 11.11% |
| Return on Assets (ROA) | 6.62% |
| Return on Invested Capital (ROIC) | 9.71% |
| Return on Capital Employed (ROCE) | 11.41% |
| Weighted Average Cost of Capital (WACC) | 9.63% |
| Revenue Per Employee | $2.54M |
| Profits Per Employee | $222,553 |
| Employee Count | 3,000 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 0.92 |
Taxes
In the past 12 months, TMHC has paid $216.20 million in taxes.
| Income Tax | 216.20M |
| Effective Tax Rate | 24.18% |
Stock Price Statistics
The stock price has increased by +9.11% in the last 52 weeks. The beta is 1.58, so TMHC's price volatility has been higher than the market average.
| Beta (5Y) | 1.58 |
| 52-Week Price Change | +9.11% |
| 50-Day Moving Average | 61.31 |
| 200-Day Moving Average | 62.86 |
| Relative Strength Index (RSI) | 56.93 |
| Average Volume (20 Days) | 1,512,595 |
Short Selling Information
The latest short interest is 5.39 million, so 5.77% of the outstanding shares have been sold short.
| Short Interest | 5.39M |
| Short Previous Month | 5.50M |
| Short % of Shares Out | 5.77% |
| Short % of Float | 5.81% |
| Short Ratio (days to cover) | 3.87 |
Income Statement
In the last 12 months, TMHC had revenue of $7.61 billion and earned $667.66 million in profits. Earnings per share was $6.72.
| Revenue | 7.61B |
| Gross Profit | 1.72B |
| Operating Income | 1.01B |
| Pretax Income | 894.16M |
| Net Income | 667.66M |
| EBITDA | 1.06B |
| EBIT | 1.01B |
| Earnings Per Share (EPS) | $6.72 |
Balance Sheet
The company has $652.93 million in cash and $2.41 billion in debt, giving a net cash position of -$1.76 billion or -$18.86 per share.
| Cash & Cash Equivalents | 652.93M |
| Total Debt | 2.41B |
| Net Cash | -1.76B |
| Net Cash Per Share | -$18.86 |
| Equity (Book Value) | 6.25B |
| Book Value Per Share | 66.04 |
| Working Capital | 7.33B |
Cash Flow
In the last 12 months, operating cash flow was $729.68 million and capital expenditures -$41.82 million, giving a free cash flow of $687.86 million.
| Operating Cash Flow | 729.68M |
| Capital Expenditures | -41.82M |
| Depreciation & Amortization | 41.90M |
| Net Borrowing | 99.43M |
| Free Cash Flow | 687.86M |
| FCF Per Share | $7.36 |
Margins
Gross margin is 22.61%, with operating and profit margins of 13.32% and 8.77%.
| Gross Margin | 22.61% |
| Operating Margin | 13.32% |
| Pretax Margin | 11.75% |
| Profit Margin | 8.77% |
| EBITDA Margin | 13.87% |
| EBIT Margin | 13.32% |
| FCF Margin | 9.04% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.81% |
| Shareholder Yield | 5.81% |
| Earnings Yield | 11.37% |
| FCF Yield | 11.71% |
Analyst Forecast
The average price target for TMHC is $71.71, which is 14.06% higher than the current price. The consensus rating is "Buy".
| Price Target | $71.71 |
| Price Target Difference | 14.06% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
TMHC has an Altman Z-Score of 3.82 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.82 |
| Piotroski F-Score | 5 |